In the last 12 months, insiders at Sonnet BioTherapeutics Holdings, Inc. ($SONN) filed 39 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
Sonnet BioTherapeutics Holdings, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Dexter Susan (Director) — 1 transaction totaling $0
- Dyrness Albert D. (Director) — 3 transactions totaling $0
- Cross John Harry III (Chief Financial Officer) — 1 transaction totaling $0
- MCANDREW STEPHEN J (Chief Business Officer) — 2 transactions totaling $0
- Griffith Donald J. (Chief Financial Officer) — 2 transactions totaling $0
View all SEC Filings for Sonnet BioTherapeutics Holdings, Inc. (SONN).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 2, 2025 | Kenney Richard T | Chief Medical Officer | F | Common Stock | 16891 | $0.00 | 69,614.0000 | 7,077,352 | 19.53% | 0.24% |
| Dec. 2, 2025 | Kenney Richard T | Chief Medical Officer | M | Common Stock | 86505 | $0.00 | 86,505.0000 | 7,077,352 | 9999.99% | 1.22% |
| Dec. 2, 2025 | Kenney Richard T | Chief Medical Officer | D | Common Stock | 9374 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.13% |
| Dec. 2, 2025 | Kenney Richard T | Chief Medical Officer | M | Series 5 Preferred Stock | 200 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.00% |
| Dec. 2, 2025 | Kenney Richard T | Chief Medical Officer | D | Warrant (Common Stock) | 320000 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 4.52% |
| Dec. 2, 2025 | Kenney Richard T | Chief Medical Officer | M | Warrant (Common Stock) | 86505 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 1.22% |
| Dec. 2, 2025 | Kenney Richard T | Chief Medical Officer | D | Common Stock | 163760 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 2.31% |
| Dec. 2, 2025 | Kenney Richard T | Chief Medical Officer | M | Common Stock | 163760 | $0.00 | 163,760.0000 | 7,077,352 | 9999.99% | 2.31% |
| Dec. 2, 2025 | Kenney Richard T | Chief Medical Officer | D | Common Stock | 69614 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.98% |
| Dec. 2, 2025 | Dexter Susan | Director | D | Common Stock | 9643 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.14% |
| Dec. 2, 2025 | Griffith Donald J. | Chief Financial Officer | D | Common Stock | 10375 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.15% |
| Dec. 2, 2025 | MCANDREW STEPHEN J | Chief Business Officer | D | Common Stock | 6446 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.09% |
| Dec. 2, 2025 | Dyrness Albert D. | Director | D | Common Stock | 4537 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.06% |
| Dec. 2, 2025 | Bhatt Nailesh | Director | D | Common Stock | 10547 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.15% |
| Dec. 2, 2025 | Cini John K. | Director | D | Common Stock | 14116 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.20% |
| Dec. 2, 2025 | Rao Raghu | Chief Executive Officer | D | Common Stock | 22356 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.32% |
| Dec. 2, 2025 | McNeill Lori | Director | D | Common Stock | 4394 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.06% |
| June 30, 2025 | Kenney Richard T | Chief Medical Officer | A | Warrant | 86505 | $0.00 | 86,505.0000 | 650,284 | 9999.99% | 13.30% |
| July 14, 2025 | Kenney Richard T | Chief Medical Officer | A | Warrant | 320000 | $0.00 | 320,000.0000 | 3,332,728 | 9999.99% | 9.60% |
| July 14, 2025 | Kenney Richard T | Chief Medical Officer | A | Series 5 Preferred Stock | 200 | $0.00 | 200.0000 | 3,332,728 | 9999.99% | 0.01% |
| July 11, 2025 | Cini John K. | Chief Scientific Officer | A | Common Stock | 12000 | $0.00 | 14,116.0000 | 3,332,728 | 567.11% | 0.36% |
| July 11, 2025 | Dexter Susan | Chief Technical Officer | A | Common Stock | 8000 | $0.00 | 9,643.0000 | 3,332,728 | 486.91% | 0.24% |
| July 11, 2025 | Bhatt Nailesh | Director | A | Common Stock | 10000 | $0.00 | 10,547.0000 | 3,332,728 | 1828.15% | 0.30% |
| July 11, 2025 | Kenney Richard T | Chief Medical Officer | A | Common Stock | 8000 | $0.00 | 9,374.0000 | 3,332,728 | 582.24% | 0.24% |
| July 11, 2025 | Griffith Donald J. | Chief Financial Officer | A | Common Stock | 10000 | $0.00 | 10,375.0000 | 3,332,728 | 2666.67% | 0.30% |
| July 11, 2025 | McNeill Lori | Director | A | Common Stock | 4000 | $0.00 | 4,394.0000 | 3,332,728 | 1015.23% | 0.12% |
| July 11, 2025 | MCANDREW STEPHEN J | Chief Business Officer | A | Common Stock | 6000 | $0.00 | 6,446.0000 | 3,332,728 | 1345.29% | 0.18% |
| July 11, 2025 | Rao Raghu | Interim CEO | A | Common Stock | 20000 | $0.00 | 22,356.0000 | 3,332,728 | 848.90% | 0.60% |
| July 11, 2023 | Dyrness Albert D. | Director | A | Common Stock | 4000 | $0.00 | 4,537.0000 | 0 | 744.88% | 0.00% |
| Dec. 11, 2023 | Kenney Richard T | Chief Medical Officer | A | Common Stock | 1271 | $0.00 | 1,374.0000 | 0 | 1233.98% | 0.00% |
| Dec. 11, 2023 | Bhatt Nailesh | Director | A | Common Stock | 373 | $0.00 | 547.0000 | 0 | 214.37% | 0.00% |
| Dec. 11, 2023 | Cross John Harry III | Chief Financial Officer | A | Common Stock | 1452 | $0.00 | 1,588.0000 | 0 | 47.76% | 0.00% |
| Dec. 11, 2023 | Mohan Pankaj | Chairman, President and CEO | A | Common Stock | 7554 | $0.00 | 15,367.0000 | 0 | 96.69% | 0.00% |
| Dec. 11, 2023 | Cini John K. | Chief Scientific Officer | A | Common Stock | 1888 | $0.00 | 2,116.0000 | 0 | 828.07% | 0.00% |
| Dec. 11, 2023 | Griffith Donald J. | Director | A | Common Stock | 317 | $0.00 | 375.0000 | 0 | 546.55% | 0.00% |
| Dec. 11, 2023 | Rao Raghu | Director | A | Common Stock | 373 | $0.00 | 2,356.0000 | 0 | 18.81% | 0.00% |
| Dec. 11, 2023 | Dyrness Albert D. | Director | A | Common Stock | 373 | $0.00 | 537.0000 | 0 | 227.44% | 0.00% |
| Dec. 11, 2023 | McNeill Lori | Director | A | Common Stock | 373 | $0.00 | 394.0000 | 0 | 1776.19% | 0.00% |
| Dec. 11, 2023 | Dexter Susan | Chief Technical Officer | A | Common Stock | 1452 | $0.00 | 1,643.0000 | 0 | 760.21% | 0.00% |